Publications by authors named "Daniel Reidenbach"

Claim this Profile
C
CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy.
Arne Billmeier, Krutika Khinvasara, Franziska Lang, Julia Mohr, Daniel Reidenbach

Hum Vaccin Immunother· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PeakVI: A deep generative model for single-cell chromatin accessibility analysis.
Tal Ashuach, Daniel A Reidenbach, Adam Gayoso, Nir Yosef

Cell Rep Methods· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA therapeutics in cancer immunotherapy.
Jan D Beck, Daniel Reidenbach, Nadja Salomon, Ugur Sahin, Özlem Türeci

Mol Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy.
Jan David Beck, Matthias Birtel, Erik Haefner, Isabell Sofia Keil, Daniel Reidenbach

Hum Vaccin Immunother· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CIMT 2018: Pushing frontiers in cancer immunotherapy - Report on the 16 Annual Meeting of the Association for Cancer Immunotherapy.
Jan Beck, Matthias Birtel, Daniel Reidenbach, Nadja Salomon, Mustafa Diken

Hum Vaccin Immunother· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression.
Julia M A Pickl, Diana Tichy, Vladimir Y Kuryshev, Yanis Tolstov, Michael Falkenstein, Daniel Reidenbach

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis